XML 94 R81.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Amounts attributable to Celanese Corporation        
Earnings (loss) from continuing operations $ 118 $ 952 $ 395 $ 1,265
Earnings (loss) from discontinued operations (2) (1) (3) (3)
Net earnings (loss) $ 116 $ 951 $ 392 $ 1,262
Weighted average shares - basic (in shares) 109,338,977 108,918,986 109,241,174 108,814,288
Incremental shares attributable to equity awards(1) [1] 196,060 520,500 276,125 523,752
Weighted average shares - diluted 109,535,037 109,439,486 109,517,299 109,338,040
[1] Excludes stock options to purchase 293,045 and 219,963 shares of Common Stock for the three months ended September 30, 2024 and 2023, respectively; and 19 and 0 equity award shares for the three months ended September 30, 2024 and 2023, respectively, as their effect would have been antidilutive. Excludes stock options to purchase 149,643 and 190,651 shares of Common Stock for the nine months ended September 30, 2024 and 2023, respectively; and 74 and 42,998 equity award shares for the nine months ended September 30, 2024 and 2023, respectively, as their effect would have been antidilutive.